Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc.

Healthcare

NASDAQ:ACRS · NASDAQ Global Select

Market Cap $533.03M Beta 0.80 P/E (TTM) -8.2
$4.50 +0.57%

+$0.03 today

52W Low $1.34High $5.15

Vol 4.32M · Avg 1.40M

EPS (TTM) -$0.54Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+223.74%

Period High

$5.09

Period Low

$1.39

Latest

$4.50

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health
BI

BioAge Labs, Inc.

NASDAQ:BIOA

$770.69M

Allogene Therapeutics, Inc.

Allogene Therapeutics, Inc.

NASDAQ:ALLO

$484.08M

Cabaletta Bio, Inc.

Cabaletta Bio, Inc.

NASDAQ:CABA

$467.15M

908 Devices Inc.

908 Devices Inc.

NASDAQ:MASS

$329.17M

NeoGenomics, Inc.

NeoGenomics, Inc.

NASDAQ:NEO

$283.66M

Senseonics Holdings, Inc.

Senseonics Holdings, Inc.

NASDAQ:SENS

$272.50M

Editas Medicine, Inc.

Editas Medicine, Inc.

NASDAQ:EDIT

$253.56M

OM

Owens & Minor, Inc.

OMI

$207.07M

Exagen Inc.

Exagen Inc.

NASDAQ:XGN

$105.46M

MD

MDxHealth S.A.

MDXH

$27.94M

What is the latest ACRS filing?

The latest filing shown is 4 dated Jun 8, 2026.

How many recent filings does ACRS have?

Intrinsic Alpha currently shows 20 recent filings for ACRS.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.